Navigation Links
Registration Opens Today for ASGCT's 23rd Annual Meeting in Boston

Registration is now open for the American Society of Gene & Cell Therapy’s (ASGCT) 23rd Annual Meeting, which will be held at the Hynes Convention Center May 12-15, 2020, in Boston. The meeting is the premier event in the field of gene and cell therapy and brings together scientists, physicians, patient advocates, and other stakeholders with the goal of advancing gene and cell therapies to alleviate human disease.

The 23rd Annual Meeting is expected to be the Society’s largest ever, and attendees are encouraged to register early and to reserve their hotel rooms as soon as possible as the latter will sell out well before the meeting. An early registration discount is available through April 10, and groups of five or more are eligible for an additional discount. Pre-Meeting Workshops and the Closing Night Reception can be added to annual meeting registration.

Abstract submission for the 23rd Annual Meeting is now open and runs through January 29.
International attendees can generate invitation letters online to apply for a VISA immediately after registering or submitting an abstract. More information about registration is available on the annual meeting website.

Hotel blocks for the Sheraton Boston Hotel and Boston Marriott Copley Place are also available now. ASGCT room blocks historically sell out months before the annual meeting, and once the ASGCT block is completely full, there's no guarantee attendees will be able to get the same room rate during the meeting.

More details about annual meeting programming will be posted on the website as they are confirmed. For any questions about the annual meeting, please contact [ __title__ ].

The American Society of Gene & Cell Therapy is the primary professional membership organization for scientists, physicians, patient advocates, and other professionals with interest in gene and cell therapy. Our members work in a wide range of settings including universities, hospitals, government agencies, foundations, biotechnology and pharmaceutical companies. ASGCT advances knowledge, awareness, and education leading to the discovery and clinical application of gene and cell therapies to alleviate human disease to benefit patients and society.

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related biology technology :

1. NanoScientific Symposium on SPM at SUNY Polytechnic Announces Registration for Live Stream of Event Sept. 19, 2018
2. Biohaven Files Registration Statement for Proposed Public Offering of its Common Shares
3. CannaTech, Israels 3rd Annual Summit for Accelerating Cannabis Innovation Announces Registration
4. Morf Playbook™ Training on Smartphones Presents New Course on Medical Device Establishment Registration and Listing
5. MEI Pharma Announces Positive Results from Phase II Study of Pracinostat in Acute Myeloid Leukemia, Plans to Initiate Phase III Registration Study
6. 2016 iLab/CORES User Group Conference Open for Registration
7. Conferee Registration Opens for Pittcon 2016
8. ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma
9. ProNAi Therapeutics Files Registration Statement for Proposed Initial Public Offering
10. Nivalis Therapeutics Files Registration Statement for Initial Public Offering of Common Stock
11. Integrates Engagement Management Technology, Captive Reach, Providing a Robust User Experience for Mobile-first Registration Platform
Post Your Comments:
(Date:12/4/2019)... ... ... A new survey by MedReps ( ), a career site for medical ... companies to work for in 2020. , The 9th Annual Best Places ... community to identify which medical sales companies are currently the most sought-after in the ...
(Date:12/4/2019)... Lafayette, Indiana (PRWEB) , ... December 04, 2019 ... ... improved strategy to further enhance dissolution and stabilize amorphous materials. Additionally, their PDF ... and enhance the ability to describe these compositions both in regulatory and patent ...
(Date:11/22/2019)... ... November 22, 2019 , ... ... firm, hosted a live webinar covering a step-by-step cold chain validation guide ... conjugates, and cell therapies. Targeting complex cold chain biopharmaceutical industry leaders, the ...
(Date:11/12/2019)... ... November 12, 2019 , ... REPROCELL Inc. a ... selected by Lantern Pharma to provided preclinical screening and drug sensitivity for its ... points using panels of unique and genetically edited cell lines from various tumors. ...
Breaking Biology Technology:
(Date:11/20/2019)... ... November 20, 2019 , ... BioInformatics Inc., part of Science and Medicine ... announced the winners of the Life Science Industry Awards for the most innovative new ... Awards – Innovation: , Most Innovative New Product – Cell Biology, ...
(Date:11/14/2019)... (PRWEB) , ... November 13, 2019 , ... ... that Robert Peterson, RAC , a regulatory affairs and program management executive ... biopharmaceutical and medical device industries, has joined the firm as an Expert Consultant. ...
(Date:11/12/2019)... IRVINE, Calif. (PRWEB) , ... November 12, 2019 ... ... an open call for proposals from nonprofit U.S. universities and research institutions for ... grant will provide support of up to $1.2 million per site for the ...
Breaking Biology News(10 mins):